Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Martin Diggle Insider Profile
11 Followers
Martin Diggle, Director, Ten Percent Owner at Proteome Sciences, holds 119.91M shares in Scancell Holdings (Ticker: GB:SCLP), holds 67.79M shares in Proteome Sciences (Ticker: GB:PRM), holds 10.74M shares in Oxford BioMedica (Ticker: OXBDF). Most recently, Martin Diggle Bought ― shares of Scancell Holdings on Dec 01, 2023 for an estimated value of 240.00K.
Martin Diggle Proteome Sciences (PRM)Director, Ten Percent Owner
Proteome Sciences (PRM)
Director, Ten Percent Owner
Ranked #112 out of 98,624 Corporate Insiders
Profitable Transactions
43 out of 81 Profitable Transactions
Average Return
+42.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Martin Diggle holds in companies
Most Profitable Insider Trade
The most profitable trade made by Martin Diggle
Martin Diggle's Trading History
Proteome Sciences
Apr 14, 2023
Director, Ten Percent Owner
Informative Buy
7.90K
£2.38M
Oxford BioMedica
Oct 23, 2020
Director, Ten Percent Owner
Informative Buy
195.00K
$44.03M
Scancell Holdings
Dec 01, 2023
Director, Ten Percent Owner
Informative Buy
240.00K
£10.97M
List of latest transactions for each holding click on a transaction to see Martin Diggle's performance on stock
You May Also Like
Martin Diggle insider profile FAQ
What is the percentage of profitable transactions made by Martin Diggle?
The percentage of profitable transactions made by Martin Diggle is 53%.
What is the average return per transaction made by Martin Diggle?
The average return per transaction made by Martin Diggle is 42.60%.
What stocks does Martin Diggle hold?
Martin Diggle holds: GB:PRM, OXBDF, GB:SCLP stocks.
What was Martin Diggle’s latest transaction?
Martin Diggle latest transaction was an Informative Buy of 240.00K.
What was Martin Diggle's most profitable transaction?
Martin Diggle’s most profitable transaction was an Informative Buy of OXBDF stock on September 15, 2017. The return on the trade was 800.00%.
What is Martin Diggle's role in Proteome Sciences?
Martin Diggle's role in Proteome Sciences is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.